SHARON FELICES: Open Payments
NPI 1871160911 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 36 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $0 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $342 |
| ABBVIE INC. | 7 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| GENZYME CORPORATION | 2 | $58 |
| Intercept Pharmaceuticals, Inc. | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, EOHILIA, OCALIVA, TERLIVAZ.
Industry payments across PA — which companies pay providers there.
